- Home
- SWKH vs KRRO Comparison
SWKH vs KRRO Comparison
Compare SWKH & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SWKH
- KRRO
- Stock Information
- Founded
- SWKH 1996
- KRRO 2014
- Country
- SWKH United States
- KRRO United States
- Employees
- SWKH N/A
- KRRO N/A
- Industry
- SWKH Diversified Financial Services
- KRRO Biotechnology: Pharmaceutical Preparations
- Sector
- SWKH Finance
- KRRO Health Care
- Exchange
- SWKH Nasdaq
- KRRO Nasdaq
- Market Cap
- SWKH 179.1M
- KRRO 147.4M
- IPO Year
- SWKH 1999
- KRRO 2019
- Fundamental
- Price
- SWKH $14.62
- KRRO $33.18
- Analyst Decision
- SWKH Strong Buy
- KRRO Strong Buy
- Analyst Count
- SWKH 1
- KRRO 7
- Target Price
- SWKH $18.00
- KRRO $96.71
- AVG Volume (30 Days)
- SWKH 12.9K
- KRRO 219.3K
- Earning Date
- SWKH 08-14-2025
- KRRO 08-12-2025
- Dividend Yield
- SWKH N/A
- KRRO N/A
- EPS Growth
- SWKH 55.18
- KRRO N/A
- EPS
- SWKH 1.41
- KRRO N/A
- Revenue
- SWKH $37,409,000.00
- KRRO $6,281,000.00
- Revenue This Year
- SWKH $52.93
- KRRO $97.27
- Revenue Next Year
- SWKH N/A
- KRRO N/A
- P/E Ratio
- SWKH $10.36
- KRRO N/A
- Revenue Growth
- SWKH 47.31
- KRRO N/A
- 52 Week Low
- SWKH $12.00
- KRRO $10.29
- 52 Week High
- SWKH $16.24
- KRRO $98.00
- Technical
- Relative Strength Index (RSI)
- SWKH 47.97
- KRRO 84.05
- Support Level
- SWKH $14.38
- KRRO $20.20
- Resistance Level
- SWKH $15.20
- KRRO $24.69
- Average True Range (ATR)
- SWKH 0.29
- KRRO 2.81
- MACD
- SWKH 0.06
- KRRO 1.03
- Stochastic Oscillator
- SWKH 55.04
- KRRO 90.38
About SWKH SWK Holdings Corporation
SWK Holdings Corp is a healthcare capital provider. The company offers financing solutions to various life science companies, institutions, and inventors. It involves monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. Through its wholly-owned subsidiary, it also provides non-discretionary investment advisory services to institutional clients. The company's operating segments are Finance Receivables and Pharmaceutical Development Services. It generates maximum revenue from the Finance Receivables segment.
About KRRO Korro Bio Inc.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.